These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 12932669

  • 1. Tumour markers are poor predictors for relapse or progression in neuroblastoma.
    Simon T, Hero B, Hunneman DH, Berthold F.
    Eur J Cancer; 2003 Sep; 39(13):1899-903. PubMed ID: 12932669
    [Abstract] [Full Text] [Related]

  • 2. Serum vanillylmandelic acid/homovanillic acid contributes to prognosis estimation in patients with localised but not with metastatic neuroblastoma.
    Berthold F, Hunneman DH, Harms D, Käser H, Zieschang J.
    Eur J Cancer; 1992 Sep; 28A(12):1950-4. PubMed ID: 1419287
    [Abstract] [Full Text] [Related]

  • 3. Different genomic and metabolic patterns between mass screening-positive and mass screening-negative later-presenting neuroblastomas.
    Nakagawara A, Zaizen Y, Ikeda K, Suita S, Ohgami H, Nagahara N, Sera Y, Akiyama H, Kawakami K, Uchino J.
    Cancer; 1991 Nov 01; 68(9):2037-44. PubMed ID: 1913552
    [Abstract] [Full Text] [Related]

  • 4. Analysis of vanillylmandelic acid and homovanillic acid by UPLC-MS/MS in serum for diagnostic testing for neuroblastoma.
    Sadilkova K, Dugaw K, Benjamin D, Jack RM.
    Clin Chim Acta; 2013 Sep 23; 424():253-7. PubMed ID: 23830883
    [Abstract] [Full Text] [Related]

  • 5. Analytical validation and clinical application of urinary vanillylmandelic acid and homovanillic acid by LC-MS/MS for diagnosis of neuroblastoma.
    Shen Y, Li H, Lu J, Luo X, Guan Q, Cheng L.
    Biomed Chromatogr; 2019 Jun 23; 33(6):e4484. PubMed ID: 30632178
    [Abstract] [Full Text] [Related]

  • 6. Urinary homovanillic and vanillylmandelic acid in the diagnosis of neuroblastoma: report from the Italian Cooperative Group for Neuroblastoma.
    Barco S, Gennai I, Reggiardo G, Galleni B, Barbagallo L, Maffia A, Viscardi E, De Leonardis F, Cecinati V, Sorrentino S, Garaventa A, Conte M, Cangemi G.
    Clin Biochem; 2014 Jun 23; 47(9):848-52. PubMed ID: 24769278
    [Abstract] [Full Text] [Related]

  • 7. Value of random urinary homovanillic acid and vanillylmandelic acid levels in the diagnosis and management of patients with neuroblastoma: comparison with 24-hour urine collections.
    Tuchman M, Morris CL, Ramnaraine ML, Bowers LD, Krivit W.
    Pediatrics; 1985 Feb 23; 75(2):324-8. PubMed ID: 3969335
    [Abstract] [Full Text] [Related]

  • 8. Analysis of the relationship between MYCN gene and serum NSE and urinary VMA levels and neuroblastoma pathological features and prognosis.
    Zhang H, He X, Miao Q, Li L, Song J, Jiang X.
    Cell Mol Biol (Noisy-le-grand); 2024 Apr 28; 70(4):134-139. PubMed ID: 38678619
    [Abstract] [Full Text] [Related]

  • 9. Olive ingestion causing a false suspicion of relapsed neuroblastoma: A case of "oliveblastoma?".
    Flynn N, LeFebvre A, Messahel B, Hogg SL.
    Pediatr Blood Cancer; 2018 Oct 28; 65(10):e27248. PubMed ID: 29923309
    [Abstract] [Full Text] [Related]

  • 10. Development of a new biochemical test to diagnose and monitor neuroblastoma in Vietnam: homovanillic and vanillylmandelic acid by gas chromatography-mass spectrometry.
    Tran MT, Baglin J, Tran TT, Hoang KT, Phung LT, Read A, Greaves RF.
    Clin Biochem; 2014 Feb 28; 47(3):206-15. PubMed ID: 24296288
    [Abstract] [Full Text] [Related]

  • 11. Clinical usefulness of iodine-123-MIBG scintigraphy for patients with neuroblastoma detected by a mass screening survey.
    Hashimoto T, Koizumi K, Nishina T, Abe K.
    Ann Nucl Med; 2003 Dec 28; 17(8):633-40. PubMed ID: 14971604
    [Abstract] [Full Text] [Related]

  • 12. Diagnostic and prognostic markers in infants with disseminated neuroblastoma: a retrospective analysis from the Italian Cooperative Group for Neuroblastoma.
    Di Cataldo A, Dau D, Conte M, Parodi S, De Bernardi B, Giuliano M, Pession A, Viscardi E, Luksch R, Castellano A, Bertuna G, Haupt R, Italian Cooperative Group for Neuroblastoma.
    Med Sci Monit; 2009 Jan 28; 15(1):MT11-8. PubMed ID: 19114976
    [Abstract] [Full Text] [Related]

  • 13. Clinical value of combined serum CA125, NSE and 24-hour urine VMA for the prediction of recurrence in children with neuroblastoma.
    Li J, Qi Z, Chen M, Wang J, Liu X.
    Ital J Pediatr; 2023 Aug 24; 49(1):102. PubMed ID: 37620978
    [Abstract] [Full Text] [Related]

  • 14. Assessment of the diurnal variations in urinary homovanillic and vanillylmandelic acid excretion for the diagnosis and follow-up of patients with neuroblastoma.
    Tuchman M, Robison LL, Maynard RC, Ramnaraine ML, Krivit W.
    Clin Biochem; 1985 Jun 24; 18(3):176-9. PubMed ID: 4039636
    [Abstract] [Full Text] [Related]

  • 15. [Clinical evaluation of I-131 metaiodobenzylguanidine (MIBG) imaging in suspected neuroblastoma].
    Iwashita S, Nakajo M, Nakabeppu Y, Tanoue T, Yonekura R, Taguchi M, Shimabukuro K, Shinohara S, Sakata H.
    Kaku Igaku; 1989 Sep 24; 26(9):1135-47. PubMed ID: 2810911
    [Abstract] [Full Text] [Related]

  • 16. [Follow up control of stage IV neuroblastoma: 123I-MIBG scintigraphy, bone scintigraphy and catecholamine metabolites].
    Kohnert K, Lerch H, Thelen M, Jürgens H, Schober O.
    Nuklearmedizin; 1996 Dec 24; 35(6):220-4. PubMed ID: 8999421
    [Abstract] [Full Text] [Related]

  • 17. Three years of experience with random urinary homovanillic and vanillylmandelic acid levels in the diagnosis of neuroblastoma.
    Tuchman M, Ramnaraine ML, Woods WG, Krivit W.
    Pediatrics; 1987 Feb 24; 79(2):203-5. PubMed ID: 3808793
    [Abstract] [Full Text] [Related]

  • 18. Measurement of urinary vanillylmandelic acid (VMA) and homovanillic acid (HVA) for diagnosis of neural crest tumors.
    Sawada T.
    Pediatr Hematol Oncol; 1997 Feb 24; 14(4):291-3. PubMed ID: 9211532
    [No Abstract] [Full Text] [Related]

  • 19. Interchangeability between 24-hour collection and single spot urines for vanillylmandelic and homovanillic acid levels in the diagnosis of neuroblastoma.
    Cangemi G, Barco S, Reggiardo G, Viscardi E, Di Cataldo A, Garaventa A, Melioli G, Conte M.
    Pediatr Blood Cancer; 2013 Dec 24; 60(12):E170-2. PubMed ID: 23813598
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of plasma 3,4-dihydroxyphenylacetic acid (DOPAC) and plasma 3,4-dihydroxyphenylalanine (DOPA) as tumor markers in children with neuroblastoma.
    Eldrup E, Clausen N, Scherling B, Schmiegelow K.
    Scand J Clin Lab Invest; 2001 Dec 24; 61(6):479-90. PubMed ID: 11681538
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.